메뉴 건너뛰기




Volumn 298, Issue 3, 2007, Pages 285-286

Ethics of hematopoietic stem cell transplantation in type 1 diabetes mellitus: Reply [7]

Author keywords

[No Author keywords available]

Indexed keywords

HEALTH PROMOTION; HEMATOLOGIC DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INFORMED CONSENT; INSULIN DEPENDENT DIABETES MELLITUS; LETTER; MEDICAL ETHICS; PRIORITY JOURNAL; CHILD; ETHICS; METHODOLOGY; NOTE; PATIENT PARTICIPATION; RESEARCH ETHICS;

EID: 34447500175     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.298.3.285-b     Document Type: Letter
Times cited : (6)

References (6)
  • 1
    • 0019870514 scopus 로고
    • Partial preservation of pancreatic beta-cell function in children with diabetes
    • Elliott RB, Crossley JR, Berryman CC, James AG. Partial preservation of pancreatic beta-cell function in children with diabetes. Lancet. 1981;2(8247):631-632.
    • (1981) Lancet , vol.2 , Issue.8247 , pp. 631-632
    • Elliott, R.B.1    Crossley, J.R.2    Berryman, C.C.3    James, A.G.4
  • 2
    • 0024813410 scopus 로고
    • Double-blind controlled trial of azathioprine in children with newly diagnosed type I diabetes
    • Cook JJ, Hudson I, Harrison LC, et al. Double-blind controlled trial of azathioprine in children with newly diagnosed type I diabetes. Diabetes. 1989;38(6):779-783.
    • (1989) Diabetes , vol.38 , Issue.6 , pp. 779-783
    • Cook, J.J.1    Hudson, I.2    Harrison, L.C.3
  • 3
    • 0023735943 scopus 로고
    • Immunosuppression with azathioprine and prednisone in recent-onset insulin-dependent diabetes mellitus
    • Silverstein J, Maclaren N, Riley W, et al. Immunosuppression with azathioprine and prednisone in recent-onset insulin-dependent diabetes mellitus. N Engl J Med. 1988;319(10):599-604.
    • (1988) N Engl J Med , vol.319 , Issue.10 , pp. 599-604
    • Silverstein, J.1    Maclaren, N.2    Riley, W.3
  • 4
    • 0037198420 scopus 로고    scopus 로고
    • Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus
    • Herold KC, Hagopian W, Auger JA, et al. Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus. N Engl J Med. 2002;346(22):1692-1698.
    • (2002) N Engl J Med , vol.346 , Issue.22 , pp. 1692-1698
    • Herold, K.C.1    Hagopian, W.2    Auger, J.A.3
  • 5
    • 20544443927 scopus 로고    scopus 로고
    • Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes
    • Keymeulen B, Vandemeulebroucke E, Ziegler AG, et al. Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes. N Engl J Med. 2005;352(25):2598-2608.
    • (2005) N Engl J Med , vol.352 , Issue.25 , pp. 2598-2608
    • Keymeulen, B.1    Vandemeulebroucke, E.2    Ziegler, A.G.3
  • 6
    • 10044256016 scopus 로고    scopus 로고
    • Growth and development after hematopoietic cell transplantation
    • Blume KG, Forman SJ, Appelbaum FK, eds, Maiden, MA: Blackwell Publishing;
    • Sanders JE. Growth and development after hematopoietic cell transplantation. In: Blume KG, Forman SJ, Appelbaum FK, eds. Thomas' Hematopoietic Cell Transplantation. Maiden, MA: Blackwell Publishing; 2004:929-943.
    • (2004) Thomas' Hematopoietic Cell Transplantation , pp. 929-943
    • Sanders, J.E.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.